We are live on ! Find out more
EGI

EAM Global Investors Portfolio holdings

AUM $47.1M
1-Year Est. Return 320.45%
This Fund
S&P 500
This Quarter Est. Return
-1.89%
1 Year Est. Return
+320.45%
3 Year Est. Return
+2,492.23%
5 Year Est. Return
+19,933.92%
10 Year Est. Return
AUM
$183M
AUM Growth
-$64.1M
Cap. Flow
-$45M
Cap. Flow %
-24.62%
Top 10 Hldgs %
17.94%
Holding
198
New
47
Increased
23
Reduced
28
Closed
72

Sector Composition

Rank Sector Weight
1 Healthcare 30.1%
2 Technology 27.65%
3 Industrials 12.68%
4 Consumer Discretionary 5.21%
5 Consumer Staples 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPCH icon
51
Option Care Health
OPCH
$3.56B
$1.46M 0.8%
+102,034
New +$1.35M
BCRX icon
52
BioCryst Pharmaceuticals
BCRX
$2.4B
$1.45M 0.8%
+180,199
New +$1.4M
TRHC
53
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$1.45M 0.79%
22,724
EVBG
54
DELISTED
Everbridge, Inc. Common Stock
EVBG
$1.44M 0.79%
25,369
+2,693
+12% +$140K
WLDN icon
55
Willdan Group
WLDN
$1.3B
$1.43M 0.78%
+40,983
New +$1.4M
DENN
56
DELISTED
Denny's
DENN
$1.43M 0.78%
+88,402
New +$1.39M
MGNI icon
57
Magnite
MGNI
$3.55B
$1.43M 0.78%
+383,358
New +$1.46M
CRMT icon
58
America's Car Mart
CRMT
$26.9M
$1.43M 0.78%
19,703
ARWR icon
59
Arrowhead Research
ARWR
$12.4B
$1.39M 0.76%
112,124
-20,255
-15% -$277K
CWST icon
60
Casella Waste Systems
CWST
$5.69B
$1.39M 0.76%
48,823
+4,462
+10% +$135K
ATEX icon
61
Anterix
ATEX
$1.94B
$1.39M 0.76%
+37,158
New +$1.45M
NEO icon
62
NeoGenomics
NEO
$2.13B
$1.39M 0.76%
109,933
BSTC
63
DELISTED
BioSpecifics Technologies Corp.
BSTC
$1.38M 0.76%
22,789
+2,147
+10% +$128K
KNSL icon
64
Kinsale Capital Group
KNSL
$8.51B
$1.38M 0.76%
24,839
+3,795
+18% +$224K
RST
65
DELISTED
ROSETTA STONE INC
RST
$1.38M 0.75%
84,086
+21,190
+34% +$387K
LAB icon
66
Standard BioTools
LAB
$314M
$1.38M 0.75%
+159,499
New +$1.24M
AGYS icon
67
Agilysys
AGYS
$3.06B
$1.35M 0.74%
94,490
+7,018
+8% +$110K
AMRC icon
68
Ameresco
AMRC
$1.36B
$1.34M 0.74%
95,377
+20,177
+27% +$284K
INSP icon
69
Inspire Medical Systems
INSP
$1.74B
$1.34M 0.73%
31,695
FATE icon
70
Fate Therapeutics
FATE
$326M
$1.32M 0.72%
103,125
RETA
71
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.32M 0.72%
23,567
-3,954
-14% -$241K
VRS
72
DELISTED
Verso Corporation
VRS
$1.31M 0.72%
58,457
+8,263
+16% +$223K
LFVN icon
73
LifeVantage
LFVN
$85.3M
$1.27M 0.7%
+96,648
New +$1.16M
AMPH icon
74
Amphastar Pharmaceuticals
AMPH
$916M
$1.24M 0.68%
+62,426
New +$1.23M
CDNA icon
75
CareDx
CDNA
$2.42B
$1.24M 0.68%
49,129
-13,920
-22% -$358K

Similar funds

EAM Global Investors's Q4 2018 Portfolio in Review

As of Q4 2018, EAM Global Investors held 198 positions worth $183M, down 26% from $247M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

EAM Global Investors withdrew a net $45M in Q4 2018, closing 72 positions and reducing 28 holdings. Its most notable exit was GeoPark, an estimated $5.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Global Investors opened a new position in Kornit Digital worth $4.13M.

  • EAM Global Investors's largest Q4 2018 buy was Kornit Digital: 220,720 shares worth $4.13M.
  • EAM Global Investors added most to Aldeyra Therapeutics in Q4 2018, an estimated $423K increase.
  • EAM Global Investors's biggest Q4 2018 reduction was VanEck India Growth Leaders ETF, cutting an estimated $8.06M.
  • EAM Global Investors fully exited GeoPark in Q4 2018, selling an estimated $5.2M.
  • EAM Global Investors's ten largest holdings make up 18% of its $183M portfolio in Q4 2018.
  • EAM Global Investors opened 47 new positions and closed 72 in Q4 2018.
  • EAM Global Investors's portfolio value fell 26% quarter-over-quarter to $183M.

Based on EAM Global Investors's 13F filing for Q4 2018, filed 13 Feb 2019.